Have a personal or library account? Click to login
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway Cover

Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents via inhibition of PI3K/Akt/mTOR signalling pathway

By: Qing Su,  Baolin Xu,  Zhoubin Tian and  Ziling Gong  
Open Access
|Apr 2022

Authors

Qing Su

Department of Orthopedic Oncology, Yantai Shan Hospital, Yantai, China

Baolin Xu

Department of Orthopedics, The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, China

Zhoubin Tian

Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

Ziling Gong

orthogong@outlook.com

Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
DOI: https://doi.org/10.2478/acph-2022-0026 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 389 - 402
Accepted on: Dec 14, 2021
Published on: Apr 13, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2022 Qing Su, Baolin Xu, Zhoubin Tian, Ziling Gong, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.